APP and amyotrophic lateral sclerosis: In this way modulating β-secretase function and APP bioavailability could potentially have a positive effect on the stability of the cytoskeleton at the NMJ and has already been shown to delay the onset of neuronal degeneration in ALS (Rabinovich-Toidman et al., 2012).